TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00

Teladoc Health (NYSE:TDOC) had its target price decreased by TD Cowen from $16.00 to $15.00 in a report issued on Friday morning, Benzinga reports. TD Cowen currently has a hold rating on the health services provider’s stock.

Several other brokerages have also issued reports on TDOC. DA Davidson dropped their price target on Teladoc Health from $22.00 to $18.00 and set a neutral rating on the stock in a research note on Wednesday, February 21st. Royal Bank of Canada dropped their target price on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating on the stock in a research report on Wednesday, February 21st. Barclays reduced their price target on shares of Teladoc Health from $25.00 to $20.00 and set an overweight rating for the company in a report on Friday. Truist Financial dropped their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a hold rating on the stock in a report on Wednesday, March 6th. Finally, Leerink Partnrs reaffirmed a market perform rating on shares of Teladoc Health in a research report on Monday, February 26th. Twelve research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $18.73.

Teladoc Health Trading Up 3.0 %

NYSE:TDOC opened at $13.40 on Friday. Teladoc Health has a 52 week low of $12.65 and a 52 week high of $30.41. The firm’s fifty day moving average is $14.69 and its 200-day moving average is $17.67. The firm has a market cap of $2.27 billion, a P/E ratio of -9.50 and a beta of 0.94. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). The business had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The business’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.37) earnings per share. Equities analysts expect that Teladoc Health will post -1.06 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the completion of the sale, the insider now owns 57,223 shares in the company, valued at $1,097,537.14. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Teladoc Health news, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the completion of the sale, the insider now directly owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock valued at $2,038,251 in the last three months. 1.63% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Parallel Advisors LLC raised its stake in shares of Teladoc Health by 14.6% during the 4th quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock worth $87,000 after purchasing an additional 515 shares during the period. M&T Bank Corp increased its holdings in Teladoc Health by 5.5% during the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock worth $241,000 after buying an additional 584 shares during the last quarter. Van ECK Associates Corp increased its holdings in Teladoc Health by 20.3% during the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock worth $77,000 after buying an additional 606 shares during the last quarter. Arizona State Retirement System raised its position in Teladoc Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider’s stock worth $866,000 after acquiring an additional 650 shares during the period. Finally, Victory Capital Management Inc. boosted its stake in Teladoc Health by 4.3% in the third quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock valued at $334,000 after acquiring an additional 748 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.